Piyanping Antiitch

Description

PIYANGING ANTI-ITCH LOTION is a topical formulation containing 1% hydrocortisone, designed for the temporary relief of itching associated with minor skin irritations, inflammation, and rashes. This product is intended for external use only. It is manufactured in China and is available in a net weight of 0.67 oz. (20 g).

Uses and Indications

This drug is indicated for the temporary relief of itching associated with minor skin irritations, inflammation, and rashes.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children aged 2 years and older are instructed to apply the medication to the affected area no more than 3 to 4 times daily. For children under 2 years of age, the use of this medication is not recommended; healthcare professionals should be consulted for guidance.

The medication should be applied topically to the affected area, adhering to the specified frequency of administration. It is essential to ensure that the application does not exceed the recommended maximum of 3 to 4 times per day for the appropriate age group.

Contraindications

The product is contraindicated for the treatment of diaper rash; consultation with a healthcare professional is advised in such cases. Additionally, it should not be used for external genital itching in the presence of vaginal discharge; a healthcare professional should be consulted for appropriate management.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients to avoid contact with the eyes to prevent irritation or injury. Prior to initiating the use of any other hydrocortisone product, it is essential for patients to consult with a physician to ensure safety and efficacy.

In cases of external anal itching, patients must adhere strictly to the recommended daily dosage. Exceeding this dosage should only occur under the guidance of a healthcare provider. Should any bleeding occur, it is imperative to seek medical attention promptly.

Patients should be cautioned against inserting this product into the rectum using fingers, mechanical devices, or applicators, as this may lead to complications or adverse effects.

Emergency medical assistance should be sought immediately if the product is ingested. Patients or caregivers should contact a Poison Control Center without delay in such instances.

Patients are advised to discontinue use and consult their healthcare provider if their condition worsens, if symptoms persist beyond 7 days, or if symptoms resolve only to recur within a few days. These precautions are critical to ensure the safe and effective use of the product.

Side Effects

Patients using this product may experience adverse reactions, which are categorized based on their seriousness and frequency.

Serious adverse reactions include the potential for severe irritation or allergic reactions, particularly if the product is misused or applied improperly. It is crucial for patients to avoid contact with the eyes and to refrain from using any other hydrocortisone products without consulting a healthcare professional. In cases of external anal itching, patients should not exceed the recommended daily dosage unless directed by a doctor. If bleeding occurs, patients are advised to consult a doctor promptly.

Common adverse reactions may include localized irritation or discomfort at the application site. Patients should be vigilant and discontinue use if their condition worsens or if symptoms persist for more than 7 days. If symptoms clear up and then recur within a few days, it is recommended that patients seek medical advice.

This product is intended for external use only, and patients should not insert it into the rectum using fingers or any mechanical device or applicator. Adherence to these guidelines is essential to minimize the risk of adverse reactions.

Drug Interactions

The use of hydrocortisone in conjunction with other hydrocortisone products should be approached with caution. It is advised that patients do not initiate the use of any additional hydrocortisone formulations without prior consultation with a healthcare professional. This precaution is essential to avoid potential additive effects and complications associated with corticosteroid therapy. Monitoring for signs of excessive corticosteroid exposure is recommended if multiple products are used concurrently.

Packaging & NDC

Below are the non-prescription pack sizes of Piyanping Antiitch (hydrocortisone). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 2 years of age should not use this medication; caregivers are advised to consult a doctor for guidance. For children aged 2 years and older, the medication may be applied to the affected area no more than 3-4 times daily.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

The available data regarding the use of this product during pregnancy do not indicate any specific warnings or precautions. The prescribing information does not state whether the product is contraindicated in pregnant patients or if there are any associated risks to the fetus. Additionally, there are no recommendations for dosage modifications or special precautions for individuals who are pregnant. Healthcare professionals should consider the absence of specific data when advising women of childbearing potential and weigh the benefits against any potential risks when prescribing this product during pregnancy.

Lactation

Lactating mothers should consult a doctor before using this product. There is a potential for excretion in breast milk, and the safety of this product during lactation has not been established. Caution is advised when using this product while breastfeeding.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care and symptomatic treatment as necessary. This may include monitoring vital signs, providing respiratory support, and administering intravenous fluids if indicated.

Additionally, it is recommended that healthcare professionals consult local poison control centers or relevant toxicology resources for guidance on specific management protocols tailored to the substance involved in the overdose.

Documentation of the incident, including the amount and timing of the substance taken, is crucial for effective management and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the provided text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of the reach of children to prevent accidental ingestion. In the event that the medication is swallowed, patients should seek medical help or contact a Poison Control Center immediately.

Patients should be informed that this medication is not intended for the treatment of diaper rash and that they should consult a doctor for appropriate alternatives. Additionally, it is important to communicate that the medication should not be used for external genital itching, especially if there is a vaginal discharge; in such cases, patients should also seek medical advice.

Healthcare providers should instruct patients to discontinue use and consult a doctor if their condition worsens. Furthermore, patients should be advised to stop using the medication and seek medical attention if their symptoms persist for more than 7 days or if symptoms clear up and then recur within a few days.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at a controlled temperature range of 20-25°C (68-77°F) to maintain its integrity and efficacy. Proper storage conditions should be ensured to prevent any degradation of the product.

Additional Clinical Information

The product is administered topically, with a recommended application frequency of no more than 3-4 times daily for adults and children aged 2 years and older. Clinicians should advise patients to discontinue use and consult a doctor if the condition worsens, symptoms persist beyond 7 days, or if symptoms resolve and then recur within a few days.

Patients should be counseled to keep the product out of reach of children and to seek medical assistance or contact a Poison Control Center immediately if swallowed. It is important to avoid contact with the eyes and not to initiate the use of any other hydrocortisone products without consulting a healthcare professional. For external anal itching, patients should adhere to the recommended dosage and consult a doctor if bleeding occurs. Additionally, the product should not be inserted into the rectum using fingers or any mechanical device or applicator.

Drug Information (PDF)

This file contains official product information for Piyanping Antiitch, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)